120 related articles for article (PubMed ID: 7964876)
21. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
22. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
23. Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.
Comi GP; Prelle A; Bresolin N; Moggio M; Bardoni A; Gallanti A; Vita G; Toscano A; Ferro MT; Bordoni A
Brain; 1994 Feb; 117 ( Pt 1)():1-14. PubMed ID: 8149204
[TBL] [Abstract][Full Text] [Related]
24. Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.
Arahata K; Hoffman EP; Kunkel LM; Ishiura S; Tsukahara T; Ishihara T; Sunohara N; Nonaka I; Ozawa E; Sugita H
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7154-8. PubMed ID: 2674948
[TBL] [Abstract][Full Text] [Related]
25. Multiplicity of abnormal dystrophin in Becker muscular dystrophy. A Becker muscular dystrophy gene frequently produced two smaller sizes of dystrophin.
Hori S; Ohtani S; Shimizu T; Ibi T; Sahashi K; Nonaka I; Miyamoto K; Tanabe H
J Neurol Sci; 1994 Feb; 121(2):183-9. PubMed ID: 8158213
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical alterations of dystrophin in congenital muscular dystrophy.
Werneck LC; Bonilla E
Arq Neuropsiquiatr; 1995 Sep; 53(3-A):416-23. PubMed ID: 8540815
[TBL] [Abstract][Full Text] [Related]
27. Absence of dystrophin in two patients with Becker type Xp21 muscular dystrophy.
Mongini T; Palmucci L; Doriguzzi C; Chiadoò-Piat L; Restagno G
Neurosci Lett; 1992 Nov; 147(1):37-40. PubMed ID: 1480320
[TBL] [Abstract][Full Text] [Related]
28. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
Nicholson LV; Davison K; Johnson MA; Slater CR; Young C; Bhattacharya S; Gardner-Medwin D; Harris JB
J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
[TBL] [Abstract][Full Text] [Related]
29. Absence of dystrophin and spectrin in regenerating muscle fibers from Becker dystrophy patients.
Fanin M; Pegoraro E; Angelini C
J Neurol Sci; 1994 May; 123(1-2):88-94. PubMed ID: 8064327
[TBL] [Abstract][Full Text] [Related]
30. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
Shomrat R; Gluck E; Legum C; Shiloh Y
Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
[TBL] [Abstract][Full Text] [Related]
31. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.
Bushby KM; Gardner-Medwin D; Nicholson LV; Johnson MA; Haggerty ID; Cleghorn NJ; Harris JB; Bhattacharya SS
J Neurol; 1993 Feb; 240(2):105-12. PubMed ID: 8437017
[TBL] [Abstract][Full Text] [Related]
32. Dystrophin-positive myotubes in innervated muscle cultures from Duchenne and Becker muscular dystrophy patients.
Fanin M; Hoffman EP; Saad FA; Martinuzzi A; Danieli GA; Angelini C
Neuromuscul Disord; 1993 Mar; 3(2):119-27. PubMed ID: 8358237
[TBL] [Abstract][Full Text] [Related]
33. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
[TBL] [Abstract][Full Text] [Related]
34. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.
Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
J Med Genet; 1993 Sep; 30(9):737-44. PubMed ID: 8411068
[TBL] [Abstract][Full Text] [Related]
35. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
Mizuno Y; Nonaka I; Hirai S; Ozawa E
J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
[TBL] [Abstract][Full Text] [Related]
37. Muscle histology in Becker muscular dystrophy.
Kaido M; Arahata K; Hoffman EP; Nonaka I; Sugita H
Muscle Nerve; 1991 Nov; 14(11):1067-73. PubMed ID: 1745279
[TBL] [Abstract][Full Text] [Related]
38. Deletion screening of the Duchenne/Becker muscular dystrophy gene in Croatian population.
Sertić J; Barisić N; Sostarko M; Brzović Z; Stavljenić-Rukavina A
Coll Antropol; 1997 Jun; 21(1):151-6. PubMed ID: 9225508
[TBL] [Abstract][Full Text] [Related]
39. Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions.
Beggs AH; Hoffman EP; Kunkel LM
Am J Med Genet; 1992 Oct; 44(3):378-81. PubMed ID: 1488990
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetic and immunological analysis of dystrophin of a young patient with X-linked muscular dystrophy.
Ikeya K; Saito K; Hayashi K; Tanaka H; Hagiwara Y; Yoshida M; Yamauchi A; Fukuyama Y; Ishiguro T; Eguchi C
Am J Med Genet; 1992 Jun; 43(3):580-7. PubMed ID: 1605252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
